Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Asia Pacific Pharmacovigilance and Drug Safety Software Market


Asia Pacific Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1641561 | Industry: Healthcare and Social Assistance | Published On: 2022-08-02


Asia Pacific pharmacovigilance and drug safety software market will grow by 8.9% annually with a total addressable market cap of $817.5 million over 2022-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Highlighted with 30 tables and 59 figures, this 117-page report “Asia Pacific Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Country.

Based on Functionality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

Based on Clinical Phase, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

By Method, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

By Delivery Mode, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• On-premise Delivery
• On-demand Delivery

By Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Oncology
• Respiratory Disorders
• Cardiology
• Neurology
• Immunology
• Pain Management
• Other Indications

By End Users, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Business Process Outsourcing Firms (BPOs)
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Functionality, Delivery Mode and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisAsia Pacific LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 8
1.1  Industry  Definition  and  Research  Scope 8
1.1.1  Industry  Definition 8
1.1.2  Research  Scope 9
1.2  Research  Methodology 12
1.2.1  Overview  of  Market  Research  Methodology 12
1.2.2  Market  Assumption 13
1.2.3  Secondary  Data 13
1.2.4  Primary  Data 13
1.2.5  Data  Filtration  and  Model  Design 14
1.2.6  Market  Size/Share  Estimation 15
1.2.7  Research  Limitations 16
1.3  Executive  Summary 17
2  Market  Overview  and  Dynamics 20
2.1  Market  Size  and  Forecast 20
2.1.1  Impact  of  COVID-19  on  World  Economy 21
2.1.2  Impact  of  COVID-19  on  the  Market 25
2.2  Major  Growth  Drivers 27
2.3  Market  Restraints  and  Challenges 32
2.4  Emerging  Opportunities  and  Market  Trends 35
2.5  Porter’s  Fiver  Forces  Analysis 39
3  Segmentation  of  Asia  Pacific  Market  by  Functionality 43
3.1  Market  Overview  by  Functionality 43
3.2  Adverse  Event  Reporting  Software 45
3.3  Drug  Safety  Audits  Software 46
3.4  Issue  Tracking  Software 47
3.5  Fully  Integrated  Software 48
4  Segmentation  of  Asia  Pacific  Market  by  Clinical  Phase 49
4.1  Market  Overview  by  Clinical  Phase 49
4.2  Pre-clinical 51
4.3  Phase  I 52
4.4  Phase  II 53
4.5  Phase  III 54
4.6  Phase  IV 55
5  Segmentation  of  Asia  Pacific  Market  by  Method 56
5.1  Market  Overview  by  Method 56
5.2  Spontaneous  Reporting 58
5.3  Intensified  ADR  Reporting 59
5.4  Targeted  Spontaneous  Reporting 60
5.5  Cohort  Event  Monitoring 61
5.6  EHR  Mining 62
6  Segmentation  of  Asia  Pacific  Market  by  Delivery  Mode 63
6.1  Market  Overview  by  Delivery  Mode 63
6.2  On-premise  Delivery 65
6.3  On-demand  Delivery 66
7  Segmentation  of  Asia  Pacific  Market  by  Indication 67
7.1  Market  Overview  by  Indication 67
7.2  Oncology 69
7.3  Respiratory  Disorders 70
7.4  Cardiology 71
7.5  Neurology 72
7.6  Immunology 73
7.7  Pain  Management 74
7.8  Other  Indications 75
8  Segmentation  of  Asia  Pacific  Market  by  End  User 76
8.1  Market  Overview  by  End  User 76
8.2  Pharmaceutical  and  Biotechnology  Companies 78
8.3  Contract  Research  Organizations  (CROs) 79
8.4  Business  Process  Outsourcing  Firms  (BPOs) 80
8.5  Other  End  Users 81
9  Asia-Pacific  Market  2021-2031  by  Country 82
9.1  Overview  of  Asia-Pacific  Market 82
9.2  Japan 85
9.3  China 88
9.4  Australia 90
9.5  India 92
9.6  South  Korea 94
9.7  Rest  of  APAC  Region 96
10  Competitive  Landscape 98
10.1  Overview  of  Key  Vendors 98
10.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 101
10.3  Company  Profiles 102
Ab  Cube 102
Accenture  PLC 104
ArisAsia  Pacific  LLC 105
Cognizant  Technology  Solutions  Corporation 106
Ennov  Solutions  Inc. 107
Extedo  GmbH 108
Honeywell  International  Inc.  (Sparta  Systems  Inc.) 109
IQVIA  Inc. 110
Max  Application 111
Oracle  Corporation 112
Sarjen  Systems  Pvt.  Ltd. 113
United  BioSource  LLC 114
Veeva  Systems  Inc. 115
Wipro  Limited 116
RELATED  REPORTS 117
List of Tables:

Table 1. Snapshot of Asia Pacific Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Pharmacovigilance and Drug Safety Software Market 35
Table 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 43
Table 6. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 49
Table 7. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 56
Table 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 63
Table 9. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 67
Table 10. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 76
Table 11. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 83
Table 12. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 87
Table 13. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 87
Table 14. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 87
Table 15. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 89
Table 16. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 89
Table 17. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 89
Table 18. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 91
Table 19. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 91
Table 20. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 91
Table 21. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 93
Table 22. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 93
Table 23. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 93
Table 24. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 95
Table 25. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 95
Table 26. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 95
Table 27. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn 97
Table 28. Ab Cube: Company Snapshot 102
Table 29. Ab Cube: Business Segmentation 103
Table 30. Ab Cube: Product Portfolio 103
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT